Barrington James - Princeton, NJ - Role: Director of Clinical Operations (Medical Devices) Location: USA - PA / NJ My client, a small established growing company are looking for a Director of Clinical Operations to join their growing team. This candidate will ideally have experience as Senior Manager Clinical Ops, Project Director or Assoicate Director looking to step up to Director level or even Director level would be useful. As the company is growing you will need to be hands on occassionally when needed and you will be involved in growing the department if you like that challenge. They are working on an FDA approval which is exciting times and a great chance to be a part of. We have worked with them on a global basis and now we are helping on this specific search. The ideal candidate would have: Experience as a Clinical Projec Director / Project Director - ideally in Device settings Open to any Device experience in Clinical Trials Can also consider strong hands on line management and project experience Open to any other therapeutic areas Experience with managing vendors BS Degree as a minimum For more information, please send your resume to jharvey@barringtonjames.com and call me at 646 415 8221... - Permanent - Full-time
source http://jobviewtrack.com/en-in/job-1212416944160a0d531b524307074e2409491a010a12460b725d48160e1a4e1b4e106a22020e0b4917090553674e59444e05034e6418490d01020f0b45641d1a0c105e444f2f690d1d0b44004f11480e08472a50111a08074344535e2f290a0a4e17410f48250b110c43111b49374359584e590b1d6c6a11440a0b000247214502010a16590b7e41440a060d461821525d565b50/615d69b7998d007c211f3eeceaa19e6c.html?affid=f584d43114bf1954a48e3ec6be21b6ec
Subscribe to:
Post Comments (Atom)
-
Tough challenges await Rishi Sunak: Tory strategists https://ift.tt/ibXqIld has successfully eaten into the opposition poll lead - Keir Star...
-
Cryptocurrency, or "crypto" or "tokens", is all the rage right now. People are buying and using cryptos for varied purpo...
-
India likely to benefit from slump in Hong Kong market https://ift.tt/yH6rjid Several overseas institutional investors have pruned exposure ...
No comments:
Post a Comment